, de médecins répondants ne possédant pas d'ECG 29 médecins ont déclaré ne pas posséder l'appareil à ECG

, Sur les 29 médecins ne possédant pas d'ECG 25 (soit 78%) ont déclaré ne pas adresser ces patients vers un cardiologue pour réalisation d'un ECG. 7 ont déclaré les adresser vers un cardiologue

E. C. Harris and B. Barraclough, Excess mortality of mental disorder, Br J Psychiatry J Ment Sci. juill, vol.173, pp.11-53, 1998.

D. Tidemalm, M. Waern, C. Stefansson, S. Elofsson, and B. Runeson, Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services, Clin Pract Epidemiol Ment Health CP EMH, vol.4, p.23, 2008.

T. M. Laursen, T. Munk-olsen, M. Nordentoft, and P. B. Mortensen, Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia, J Clin Psychiatry. juin, vol.68, issue.6, pp.899-907, 2007.

D. Hert, M. Dekker, J. M. Wood, D. Kahl, K. G. Holt et al., Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC), Eur Psychiatry J Assoc Eur Psychiatr. sept, vol.24, issue.6, pp.412-436, 2009.

S. Brown, Excess mortality of schizophrenia. A meta-analysis, Br J Psychiatry J Ment Sci. déc, vol.171, pp.502-510, 1997.

S. Brown, M. Kim, C. Mitchell, and H. Inskip, Twenty-five year mortality of a community cohort with schizophrenia, Br J Psychiatry J Ment Sci. févr, vol.196, issue.2, pp.116-137, 2010.

S. C. Newman and R. C. Bland, Mortality in a cohort of patients with schizophrenia: a record linkage study, Can J Psychiatry Rev Can Psychiatr. mai, vol.36, issue.4, pp.239-284, 1991.

F. Casadebaig and P. A. ,

, L'Encephale. août, vol.25, issue.4, pp.329-366, 1999.

S. Leucht, T. Burkard, J. Henderson, M. Maj, and N. Sartorius, Physical illness and schizophrenia: a review of the literature, Acta Psychiatr Scand, vol.116, issue.5, pp.317-350, 2007.

B. Roshanaei-moghaddam and W. Katon, Premature mortality from general medical illnesses among persons with bipolar disorder: a review, Psychiatr Serv Wash DC. févr, vol.60, issue.2, pp.147-56, 2009.

J. Beyer, M. Kuchibhatla, K. Gersing, and K. Krishnan, Medical comorbidity in a bipolar outpatient clinical population, Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. févr, vol.30, issue.2, pp.401-405, 2005.

P. G. Surtees, N. Wainwright, R. N. Luben, N. J. Wareham, S. A. Bingham et al., Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study, Am J Psychiatry. avr, vol.165, issue.4, pp.515-538, 2008.

B. Vreeland, Bridging the gap between mental and physical health: a multidisciplinary approach, J Clin Psychiatry, vol.68, issue.4, pp.26-33, 2007.

C. W. Colton and R. W. Manderscheid, Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states, Prev Chronic Dis. avr, vol.3, issue.2, p.42, 2006.

S. Saha, D. Chant, and J. Mcgrath, A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry, vol.64, pp.1123-1154, 2007.

R. Holt and R. C. Peveler, Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future, Pract Diab Int, vol.27, pp.79-84, 2010.

J. Parks, D. Svendsen, and P. Singer, Morbidity and mortality in people with serious mental illness. Alexandria: National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council, 2006.

, Surpoids et obésité de l'adulte, prise en charge médicale de premier recours. Recommandations pour la pratique clinique, HAS, 2011.

, World Health Organization. Global strategy on diet, physical activity and health. Geneva: World Health Organization, 2003.

R. Oka, J. Kobayashi, K. Yagi, H. Tanii, S. Miyamoto et al., Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome, Diabetes Res Clin Pract. mars, vol.79, issue.3, pp.474-81, 2008.

, Examination Committee of Criteria for « Obesity Disease » in Japan, Japan Society for the Study of Obesity. New criteria for « obesity disease » in Japan, Circ J Off J Jpn Circ Soc, vol.66, issue.11, pp.987-92, 2002.

B. Zhou and C. Meta, Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cutoff points of body mass index and waist circumference in Chinese adults, Biomed Environ Sci BES. mars, vol.15, issue.1, pp.83-96, 2002.

S. L. Mcelroy, Obesity in patients with severe mental illness: overview and management, J Clin Psychiatry, vol.70, issue.3, pp.12-21, 2009.

R. Holt and R. C. Peveler, Obesity, serious mental illness and antipsychotic drugs, Diabetes Obes Metab. juill, vol.11, issue.7, pp.665-79, 2009.

N. M. Petry, D. Barry, R. H. Pietrzak, and J. A. Wagner, Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Psychosom Med. avr, vol.70, issue.3, pp.288-97, 2008.

K. M. Scott, M. A. Mcgee, J. E. Wells, O. Browne, and M. A. , Obesity and mental disorders in the adult general population, J Psychosom Res. janv, vol.64, issue.1, pp.97-105, 2008.

S. Coodin, Body mass index in persons with schizophrenia, Can J Psychiatry Rev Can Psychiatr. août, vol.46, issue.6, pp.549-55, 2001.

M. Strassnig, J. S. Brar, and R. Ganguli, Body mass index and quality of life in community-dwelling patients with schizophrenia, Schizophr Res. 1 juill, vol.62, issue.1-2, pp.73-79, 2003.

G. Maina, V. Salvi, A. Vitalucci, D. 'ambrosio, V. Bogetto et al., Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder, J Affect Disord. sept, vol.110, issue.1-2, pp.149-55, 2008.

R. S. Mcintyre, J. Z. Konarski, K. Wilkins, J. K. Soczynska, and S. H. Kennedy, Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being, Can J Psychiatry Rev Can Psychiatr. avr, vol.51, issue.5, pp.274-80, 2006.

G. E. Simon, E. J. Ludman, J. A. Linde, B. H. Operskalski, L. Ichikawa et al., Association between obesity and depression in middle-aged women, Gen Hosp Psychiatry. févr, vol.30, issue.1, pp.32-41, 2008.

L. Citrome, Risk-benefit analysis of available treatments for schizophrenia, Psychiatric Times, vol.1, pp.27-30, 2007.

P. M. Haddad and S. G. Sharma, Adverse effects of atypical antipsychotics : differential risk and clinical implications, CNS Drugs, vol.21, issue.11, pp.911-947, 2007.

J. W. Newcomer, Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review, CNS Drugs, vol.19, pp.1-93, 2005.

R. S. Mcintyre, J. Z. Konarski, V. L. Misener, and S. H. Kennedy, Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications, Ann Clin Psychiatry Off J Am Acad Clin Psychiatr. juin, vol.17, issue.2, pp.83-93, 2005.

R. S. Mcintyre, J. K. Soczynska, J. Z. Konarski, and S. H. Kennedy, The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms, Expert Opin Drug Saf. janv, vol.5, issue.1, pp.157-68, 2006.

A. J. Stunkard, M. S. Faith, and K. C. Allison, Depression and obesity. Biol Psychiatry. 1 août, vol.54, issue.3, pp.330-337, 2003.

, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes, J Clin Psychiatry. févr, vol.65, issue.2, pp.267-72, 2004.

A. J. Scheen, R. Van-winkel, D. Hert, and M. A. , Traitements neuroleptiques et troubles metaboliques, Médecine des maladies Métaboliques, vol.2, pp.593-602, 2008.

, OMS : rapport mondial sur le diabète

A. J. Scheen, D. Hert, and M. A. , Abnormal glucose metabolism in patients treated with antipsychotics, Diabetes Metab. juin, vol.33, issue.3, pp.169-75, 2007.

R. Holt, C. Bushe, and L. Citrome, Diabetes and schizophrenia 2005: are we any closer to understanding the link?, J Psychopharmacol Oxf Engl. nov, vol.19, issue.6, pp.56-65, 2005.

D. Hert, M. Van-winkel, R. Van-eyck, D. Hanssens, L. Wampers et al., Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study, Clin Pract Epidemiol Ment Health CP EMH, vol.2, p.14, 2006.

W. W. Eaton, H. Armenian, J. Gallo, L. Pratt, and D. E. Ford, Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care, vol.19, pp.1097-102, 1996.

L. C. Brown, S. R. Majumdar, S. C. Newman, and J. A. Johnson, History of depression increases risk of type 2 diabetes in younger adults, Diabetes Care. mai, vol.28, issue.5, pp.1063-1070, 2005.

S. H. Golden, M. Lazo, M. Carnethon, A. G. Bertoni, P. J. Schreiner et al., Examining a bidirectional association between depressive symptoms and diabetes, JAMA. 18 juin, vol.299, issue.23, pp.2751-2760, 2008.

R. R. Rubin, Y. Ma, D. G. Marrero, M. Peyrot, E. L. Barrett-connor et al., Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program, Diabetes Care. mars, vol.31, issue.3, pp.420-426, 2008.

, Fiche mémo HAS : Principales dyslipidémies, stratégies de prise en charge

D. Osborn, G. Levy, I. Nazareth, I. Petersen, A. Islam et al., Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database, Arch Gen Psychiatry. févr, vol.64, issue.2, pp.242-251, 2007.

J. M. Meyer, V. G. Davis, D. C. Goff, J. P. Mcevoy, H. A. Nasrallah et al., Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1, Schizophr Res. avr, vol.101, issue.1-3, pp.273-86, 2008.

R. Van-winkel, D. Hert, M. Wampers, M. Van-eyck, D. Hanssens et al., Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder, J Clin Psychiatry. mars, vol.69, issue.3, pp.472-481, 2008.

R. Wu, J. Zhao, Z. Liu, J. Zhai, X. Guo et al., Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia, Psychopharmacology (Berl). juill, vol.186, issue.4, pp.572-580, 2006.

S. M. Grundy, Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds, J Am Coll Cardiol. 21 mars, vol.47, issue.6, pp.1093-100, 2006.

S. M. Grundy, Obesity, metabolic syndrome, and cardiovascular disease, J Clin Endocrinol Metab. juin, vol.89, issue.6, pp.2595-600, 2004.

D. E. Laaksonen, H. Lakka, L. K. Niskanen, G. A. Kaplan, J. T. Salonen et al., Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study, Am J Epidemiol. 1 déc, vol.156, issue.11, pp.1070-1077, 2002.

P. Pothiwala, S. K. Jain, and S. Yaturu, Metabolic syndrome and cancer, Metab Syndr Relat Disord. août, vol.7, issue.4, pp.279-88, 2009.

E. Giovannucci, Metabolic syndrome, hyperinsulinemia, and colon cancer: a review, Am J Clin Nutr, vol.86, issue.3, pp.836-842, 2007.

S. Moebus and A. Stang,

, Herz, vol.32, issue.7, pp.529-569, 2007.

M. Pacholczyk, T. Ferenc, and J. Kowalski, The metabolic syndrome. Part I: definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk

, Postepy Hig Med Doswiadczalnej Online, vol.62, pp.530-572, 2008.

S. M. Grundy, J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel et al., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, vol.112, issue.17, pp.2735-52, 2005.

M. A. De-hert, R. Van-winkel, D. Van-eyck, L. Hanssens, M. Wampers et al., Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication, Schizophr Res. mars, vol.83, issue.1, pp.87-93, 2006.

K. M. Saari, S. M. Lindeman, K. M. Viilo, M. K. Isohanni, M. Järvelin et al., A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study, J Clin Psychiatry. mai, vol.66, issue.5, pp.559-63, 2005.

J. P. Mcevoy, J. M. Meyer, D. C. Goff, H. A. Nasrallah, S. M. Davis et al., Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III, Schizophr Res. 1 déc, vol.80, issue.1, pp.19-32, 2005.

J. M. Meyer and S. M. Stahl, The metabolic syndrome and schizophrenia, Acta Psychiatr Scand. janv, vol.119, issue.1, pp.4-14, 2009.

M. P. Garcia-portilla, P. A. Saiz, A. Benabarre, P. Sierra, J. Perez et al., The prevalence of metabolic syndrome in patients with bipolar disorder, J Affect Disord. févr, vol.106, issue.1-2, pp.197-201, 2008.

R. Basu, J. S. Brar, K. Chengappa, V. John, H. Parepally et al., The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype, Bipolar Disord. août, vol.6, issue.4, pp.314-322, 2004.

M. De-hert, C. U. Correll, J. Bobes, M. Cetkovich-bakmas, D. Cohen et al., Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care, World Psychiatry Off J World Psychiatr Assoc WPA. févr, vol.10, issue.1, pp.52-77, 2011.

, World Health Organization. The world health report 2003: shaping the future. Geneva: World Health Organization, 2003.

S. C. Smith, E. Amsterdam, G. J. Balady, R. O. Bonow, G. F. Fletcher et al., Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II, Circulation. 4 janv, vol.101, issue.1, pp.12-16, 2000.

T. M. Laursen, T. Munk-olsen, E. Agerbo, C. Gasse, and P. B. Mortensen, Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder, Arch Gen Psychiatry. juill, vol.66, issue.7, pp.713-733, 2009.

A. Brown, D. A. Barton, and G. W. Lambert, Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment, CNS Drugs, vol.23, issue.7, pp.583-602, 2009.

C. H. Hennekens, A. R. Hennekens, D. Hollar, and D. E. Casey, Schizophrenia and increased risks of cardiovascular disease, Am Heart J. déc, vol.150, issue.6, pp.1115-1136, 2005.

L. C. Bresee, S. R. Majumdar, S. B. Patten, and J. A. Johnson, Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study, Schizophr Res. mars, vol.117, issue.1, pp.75-82, 2010.

B. Ruo, J. S. Rumsfeld, M. A. Hlatky, H. Liu, W. S. Browner et al., Depressive symptoms and health-related quality of life: the Heart and Soul Study, JAMA. 9 juill, vol.290, issue.2, pp.215-236, 2003.

R. Rugulies, Depression as a predictor for coronary heart disease. a review and meta-analysis, Am J Prev Med. juill, vol.23, issue.1, pp.51-61, 2002.

I. S. Khawaja, J. J. Westermeyer, P. Gajwani, and R. E. Feinstein, Depression and coronary artery disease: the association, mechanisms, and therapeutic implications, Psychiatry Edgmont Pa Townsh. janv, vol.6, issue.1, pp.38-51, 2009.

J. A. Blumenthal, Depression and coronary heart disease: association and implications for treatment, Cleve Clin J Med. mars, vol.75, issue.2, pp.48-53, 2008.

H. Lin, F. Hsiao, S. Pfeiffer, Y. Hwang, and H. Lee, An increased risk of stroke among young schizophrenia patients, Schizophr Res. avr, vol.101, issue.1-3, pp.234-275, 2008.

S. M. Curkendall, J. Mo, D. B. Glasser, R. Stang, M. Jones et al., Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada, J Clin Psychiatry. mai, vol.65, issue.5, pp.715-735, 2004.

H. Lin, S. Tsai, and H. Lee, Increased risk of developing stroke among patients with bipolar disorder after an acute mood episode: a six-year follow-up study, J Affect Disord. juin, vol.100, issue.1-3, pp.49-54, 2007.

F. M. Nilsson and L. V. Kessing, Increased risk of developing stroke for patients with major affective disorder--a registry study, Eur Arch Psychiatry Clin Neurosci. déc, vol.254, issue.6, pp.387-91, 2004.

S. L. Larson, P. L. Owens, D. Ford, and W. Eaton, Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study, Stroke. sept, vol.32, issue.9, pp.1979-83, 2001.

A. H. Glassman and J. T. Bigger, Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death, Am J Psychiatry, vol.158, issue.11, pp.1774-82, 2001.

H. J. Witchel, J. C. Hancox, and D. J. Nutt, Psychotropic drugs, cardiac arrhythmia, and sudden death, J Clin Psychopharmacol. févr, vol.23, issue.1, pp.58-77, 2003.

W. A. Ray, C. P. Chung, K. T. Murray, K. Hall, and C. M. Stein, Atypical antipsychotic drugs and the risk of sudden cardiac death, N Engl J Med. 15 janv, vol.360, issue.3, pp.225-260, 2009.

S. R. Marder, S. M. Essock, A. L. Miller, R. W. Buchanan, D. E. Casey et al., Physical health monitoring of patients with schizophrenia, Am J Psychiatry. août, vol.161, issue.8, pp.1334-1383, 2004.

, Extrapiramidal syndrom, anticholinergic effects and orthostatic hypotension induced by antipsycotic drugs under everyday practice conditions in Italy: the PPHSS Study

D. E. Casey, Metabolic issues and cardiovascular disease in patients with psychiatric disorders, Am J Med. avr, vol.118, issue.2, pp.15-22, 2005.

R. Février, S. Bryssine, and D. Valon, Comorbidités somatiques en psychiatrie, Santé mentale, n°90, Septembre, pp.29-35, 2004.

K. J. Gold, A. M. Kilbourne, and M. Valenstein, Primary care of patients with serious mental illness: your chance to make a difference, J Fam Pract. août, vol.57, issue.8, pp.515-540, 2008.

D. Saravane, B. Feve, Y. Frances, E. Corruble, C. Lancon et al.,

, L'Encephale. sept, vol.35, issue.4, pp.330-339, 2009.

S. D. Rosenberg, L. A. Goodman, F. C. Osher, M. S. Swartz, S. M. Essock et al., Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness, Am J Public Health. janv, vol.91, issue.1, pp.31-38, 2001.

J. M. Loftis, A. M. Matthews, and P. Hauser, Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management, Drugs, vol.66, issue.2, pp.155-74, 2006.

J. Volavka, A. Convit, P. Czobor, R. Douyon, J. O'donnell et al., HIV seroprevalence and risk behaviors in psychiatric inpatients, Psychiatry Res, vol.39, issue.2, pp.109-123, 1991.

D. L. Stewart, C. J. Zuckerman, and J. M. Ingle, HIV seroprevalence in a chronically mentally ill population, J Natl Med Assoc. juill, vol.86, issue.7, pp.519-542, 1994.

J. L. Ayuso-mateos, F. Montañés, I. Lastra, P. De-la-garza, J. Ayuso-gutiérrez et al., HIV infection in psychiatric patients: an unlinked anonymous study, Br J Psychiatry J Ment Sci. févr, vol.170, pp.181-186, 1997.

J. M. Meyer, Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis Cseropositive state hospital patients: results from Oregon State Hospital, J Clin Psychiatry. mai, vol.64, issue.5, pp.540-545, 2003.

W. D. Klinkenberg, R. J. Caslyn, G. A. Morse, R. D. Yonker, S. Mccudden et al., Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders, Compr Psychiatry. août, vol.44, issue.4, pp.293-302, 2003.

R. Filik, A. Sipos, P. G. Kehoe, T. Burns, S. J. Cooper et al., The cardiovascular and respiratory health of people with schizophrenia, Acta Psychiatr Scand. avr, vol.113, issue.4, pp.298-305, 2006.

T. Kendrick, Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness, Br J Psychiatry J Ment Sci. déc, vol.169, issue.6, pp.733-742, 1996.

Y. Ohta, Y. Nakane, M. Mine, I. Nakama, S. Michitsuji et al., The epidemiological study of physical morbidity in schizophrenics--2. Association between schizophrenia and incidence of tuberculosis, Jpn J Psychiatry Neurol. mars, vol.42, issue.1, pp.41-48, 1988.

M. Viu, S. Eiu, and B. D. Tsygankov, New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment, Probl Tuberk Bolezn Legk, vol.6, pp.6-10, 2008.

S. Himelhoch, A. Lehman, J. Kreyenbuhl, G. Daumit, C. Brown et al., Prevalence of chronic obstructive pulmonary disease among those with serious mental illness, Am J Psychiatry. déc, vol.161, issue.12, pp.2317-2326, 2004.

L. A. Copeland, E. M. Mortensen, and J. E. Zeber, Pulmonary disease among inpatient decedents: impact of schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, vol.31, pp.720-726, 2007.

V. P. Volkov,

, Probl Tuberk Bolezn Legk, issue.6, pp.24-31, 2009.

M. Ozbilen and C. E. Adams, Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs, J Clin Psychopharmacol. avr, vol.29, issue.2, pp.141-147, 2009.

J. Vernay, Quetiapine-induced ischemic colitis. A case report, vol.44, pp.538-579, 2015.

D. Hert, M. Hudyana, H. Dockx, L. Bernagie, C. Sweers et al., Secondgeneration antipsychotics and constipation: a review of the literature, Eur Psychiatry J Assoc Eur Psychiatr. janv, vol.26, issue.1, pp.34-44, 2011.

M. Barchana, Journal of Affective Disorders, vol.108, pp.43-48, 2008.

Y. Barak, A. Achiron, M. Mandel, I. Mirecki, and D. Aizenberg, Reduced cancer incidence among patients with schizophrenia, Cancer. 15 déc, vol.104, issue.12, pp.2817-2838, 2005.

M. Cohen, B. Dembling, and J. Schorling, The association between schizophrenia and cancer: a population-based mortality study, Schizophr Res, vol.57, pp.139-185, 2002.

J. Hippisley-cox, Y. Vinogradova, C. Coupland, and C. Parker, Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study, Arch Gen Psychiatry. déc, vol.64, issue.12, pp.1368-76, 2007.

S. Macdonald, J. Halliday, T. Macewan, V. Sharkey, S. Farrington et al., Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study, Br J Psychiatry J Ment Sci. janv, vol.182, pp.50-56, 2003.

S. M. Smith, V. O'keane, and R. Murray, Sexual dysfunction in patients taking conventional antipsychotic medication, Br J Psychiatry J Ment Sci. juill, vol.181, pp.49-55, 2002.

B. Kasperek-zimowska, W. A. Brodniak, and A. Sarol-kulka,

, Psychiatr Pol. févr, vol.42, issue.1, pp.97-104, 2008.

S. M. Laurent and A. D. Simons, Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension, Clin Psychol Rev, vol.29, issue.7, pp.573-85, 2009.

K. Williams and M. F. Reynolds, Sexual dysfunction in major depression, CNS Spectr. août, vol.11, issue.8, pp.19-23, 2006.

J. Peuskens, L. Pani, and M. De-hert, Antipsychotics and hyperprolactinemia

M. Baggaley, Sexual dysfunction in schizophrenia: focus on recent evidence, Hum Psychopharmacol. avr, vol.23, issue.3, pp.201-210, 2008.

K. U. Lee, Y. M. Lee, and J. M. Nam, Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting, Psychiatry Investig, vol.7, pp.55-64, 2010.

S. A. Montgomery, D. S. Baldwin, and A. Riley, Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction, J Affect Disord. mai, vol.69, issue.1-3, pp.119-159, 2002.

A. L. Montejo, G. Llorca, J. A. Izquierdo, and F. Rico-villademoros, Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction, J Clin Psychiatry, vol.62, issue.3, pp.10-21, 2001.

M. Misra, G. I. Papakostas, and A. Klibanski, Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism, J Clin Psychiatry. déc, vol.65, issue.12, pp.1760-1761, 2004.

M. Lean, D. Smedt, and G. , Schizophrenia and osteoporosis, Int Clin Psychopharmacol. janv, vol.19, issue.1, pp.31-36, 2004.

D. B. Clark, Dental care for the patient with bipolar disorder, J Can Dent Assoc. janv, vol.69, issue.1, pp.20-24, 2003.

S. Lewis, R. G. Jagger, and E. Treasure, The oral health of psychiatric in-patients in South Wales. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent, vol.21, pp.182-188, 2001.

A. Thomas, E. Lavrentzou, C. Karouzos, and C. Kontis, Factors which influence the oral condition of chronic schizophrenia patients. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent, avr, vol.16, issue.2, pp.84-90, 1996.

E. Velasco, G. Machuca, A. Martinez-sahuquillo, V. Rios, J. Lacalle et al., Dental health among institutionalized psychiatric patients in Spain. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent, déc, vol.17, issue.6, pp.203-209, 1997.

B. Hede, Dental health behavior and self-reported dental health problems among hospitalized psychiatric patients in Denmark, Acta Odontol Scand. févr, vol.53, issue.1, pp.35-40, 1995.

, British Society for Disability and Oral Health. Oral health care for people with mental health problems -guidelines and recommendations

A. H. Friedlander, I. K. Friedlander, and S. R. Marder, Bipolar I disorder: psychopathology, medical management and dental implications, J Am Dent Assoc, vol.133, issue.9, pp.1209-1226, 1939.

S. Mantelet, V. Sabran-guillin, and P. Hardy, Epidémiologie des associations entre troubles mentaux et affections somatiques, EMC, 1998.

I. Besnard, Hyperprolactinémies induites par les antipsychotiques : physiopathologie, clinique et surveillance. Encéphale, 2013.

R. J. Flanagan and L. Dunk, Haematological toxicity of drugs used in psychiatry, Hum Psychopharmacol. janv, vol.23, issue.1, pp.27-41, 2008.

K. Movig, H. Leufkens, A. W. Lenderink, V. Van-den-akker, P. Hodiamont et al., Association between antidepressant drug use and hyponatraemia: a case-control study, Br J Clin Pharmacol. avr, vol.53, issue.4, pp.363-372, 2002.

S. K. Wright and S. Schroeter, Hyponatremia as a complication of selective serotonin reuptake inhibitors, J Am Acad Nurse Pract. janv, vol.20, issue.1, pp.47-51, 2008.

E. Corruble and P. Hardy, Observance du traitement en psychiatrie, EncyclMédChir (Editions Scientifiques et Médicales Elsevier SAS, Paris, tous droits réservés), p.6, 2003.

H. Millar, Management of physical health in schizophrenia: a stepping stone to treatment success, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. mai, vol.18, issue.2, pp.121-128, 2008.

, WPA : Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

, Document de travail de la GHT Ile de France sur le suivi somatique intra et extra hospitalier des patients psychiatriques